title: Wnt pathway regulation by demineralized bone is approximated by both BMP-2 and TGF-β1 signaling.
abstract: Allogeneic demineralized bone is used extensively as a clinical graft material because it has osteo/chondroinductive and osteoconductive properties. Demineralized bone powder (DBP) induces chondrogenic differentiation of human dermal fibroblasts (hDFs) in three-dimensional collagen cultures, but the initiating mechanisms have not been fully characterized nor has it been shown that bone morphogenetic proteins (BMPs) recapitulate DBP's effects on target cells. Among the many signaling pathways regulated in hDFs by DBP prior to in vitro chondrogenesis, there are changes in Wnts and their receptors that may contribute to DBP actions. This study tests the hypothesis that DBP modulation of Wnt signaling entails both BMP and TGF-β pathways. We compared the effects of DBP, TGF-β1, or BMP-2 on Wnt signaling components in hDFs by Wnt signaling macroarray, RT-PCR, in situ hybridization, and Western immunoblot analyses. Many effects of DBP on Wnt signaling components were not shared by BMP-2, and likewise DBP effects on Wnt genes and β-catenin only partially required the TGF-β pathway, as shown by selective inhibition of TGF-β/activin receptor-like kinase. The analyses revealed that 64% (16/25) of the Wnt signaling components regulated by DBP were regulated similarly by the sum of effects by BMP-2 and by TGF-β1. In conclusion, signaling mechanisms of inductive DBP in human dermal fibroblasts involve the modulation of multiple Wnt signals through both BMP and TGF-β pathways.
authors.affiliation: Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. szhou@rics.bwh.harvard.edu
authors.forename: Shuanhu
authors.initials: S
authors.lastname: Zhou
authors.forename: Shuichi
authors.initials: S
authors.lastname: Mizuno
authors.forename: Julie
authors.initials: J
authors.lastname: Glowacki
mesh_terms: D000818:Animals; D018775:Bone Demineralization Technique; D055396:Bone Morphogenetic Protein 2 / Q000502:physiology*; D002417:Cattle; D020219:Chondrogenesis / Q000187:drug effects / Q000502:physiology; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D051381:Rats; D015398:Signal Transduction / Q000502:physiology*; D053773:Transforming Growth Factor beta1 / Q000502:physiology*; D060449:Wnt Signaling Pathway / Q000187:drug effects* / Q000502:physiology
chemical_list: D055396:Bone Morphogenetic Protein 2; D053773:Transforming Growth Factor beta1